Abstract
In the retina, angiogenesis is an important component of normal physiological events such as embryonic vascular development. It is also involved in pathological processes including diabetic retinopathies and age-related macular degeneration, and tumour growth such as choroidal melanoma. Fibroblast growth factor (FGF) 2 and vascular endothelial cell growth factor (VEGF) are the two major angiogenic factors in the retina. We investigated the mechanism of proliferation and the regulation of the mitogenic properties of FGF2 and VEGF in cultures of chorocapillary endothelial cells (CEC). FGF2 is a strong mitogen for CEC and induced a 2.5-fold increase in cell proliferation after 4 days in culture in the absence of serum. In contrast, VEGF is a poor mitogen for CEC. FGF2, but not VEGF induces a large activation of MEK1, ERK1/2 and P90RSK during CEC proliferation. Pharmacological inhibition of Ras processing, and of MEK1 and ERK1/2 activation reduced only by 50% FGF2-induced cell proliferation, suggesting that there is another signalling pathway for CEC proliferation. Pharmacological inhibition of the PI 3-Kinase also inhibits by half FGF2-induced CEC proliferation. FGF2 stimulates the activation of the PI 3-K, P70S6K and Akt. Inhibition of both ERK1/2 and PI 3-K activities suppressed FGF2-induced CEC proliferation, demonstrating that CEC proliferation requires both ERKs and PI 3-K pathways. These data on the molecular mechanism and signalling may have important implications for providing more selective methods for anti-angiogenic and anti-tumoural therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alessi DR, Andjelkowic M, Cawdwell B . 1996 EMBO J. 15: 6541–6551
Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E . 1995 Nat. Med. 1: 1024–1028
Amin R, Puklin JE, Frank RN . 1994 Invest. Ophthalmol. Vis. Sci. 35: 3178–3188
Antonnetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW . 1999 J. Biol. Chem. 274: 23463–23467
Brian C, Duckworth BC, Cantley LC . 1997 J. Biol. Chem. 272: 27665–27670
Brown EJ, Albert MW, Shin TB . 1994 Nature 369: 756–758
Bryckaert M, Guillonneau X, Hecquet C, Courtois Y, Mascarelli F . 1999 Oncogene 18: 7584–7593
Buchkovich KJ, Ziff EB . 1994 Mol. Biol. Cell. 5: 1225–1241
Bullard LE, Penn JS . 2000 Ophthalmol. Vis. Sci. 41: S140
Campbell S, Khosravi-Fas R, Rossman KL, Clark GJ, Der CJ . 1998 Oncogene 17: 1395–1414
Chuang LM, Haussdorff SF, Myers MG . 1994 J. Biol. Chem. 269: 27645–27649
Cowley S, Paterson H, Kemp P, Marshal CJ . 1994 Cell 77: 841–852
Dalby KN, Morrice N, Cardwell FB, Avruch J, Chen P . 1998 J. Biol. Chem. 273: 1496–1505
D'Amore PA . 1994 Invest. Ophthalmol. Vis. Sci. 35: 3974–3979
Daum GI, Eisenmann-Tappe I, Fries HW, Troppmair J, Rapp UR . 1994 Trends Biochem. Sci. 19: 474–480
Dhanasekavan U, Premkumar Reddy E . 1998 Oncogene 17: 1447–1455
Enaida H, Ito T, Oshima Y, Sakamato T, Yago K, Kato K, Kochi H, Fukushima J . 1998 Med. Sci. 44: 43–52
Ferby IM, Waga I, Hoschino M, Kume K, Schimizu T . 1996 J. Biol. Chem. 271: 11684–11688
Folkman J, Klagsbrun M . 1987 Science 235: 442–447
Frank RN, Amin RH, Eliott D, Puklin JE, Abrams GW . 1996 Am. J. Ophthalmol. 122: 393–403
Gerber HP, McMurttrey A, Kowalski J, Yan M, Keut BA, Dixit V, Ferrara N . 1998 J. Biol. Chem. 273: 30336–30343
Guillonneau X, Tassin J, Berrou E, Bryckaert M, Courtois Y, Mascarelli F . 1996 J. Cell. Physiol. 166: 170–187
Guillonneau X, Regnier-Ricard F, Dupuis C, Courtois Y, Mascarelli F . 1998a Growth Factors. 15: 95–101
Guillonneau X, Bryckaert M, Longo-Launey C, Courtois Y, Mascarelli F . 1998b J. Biol. Chem. 273: 22367–22370
Guyer DR, Shabat AP, Green WR . 1994 In: Ryan SJ (ed). Retina 1 St Louis: Mosby p 1831
Hata Y, Rook SL, Aiello LP . 1999 Diabetes 48: 1145–1155
Hoffman S, Spee C, Murata T, Zha Cui J, Ryan SJ, Hinton DR . 1998 Graefe's Arch. Clin. Exp. Ophthalmol. 236: 779–784
Hu Q, Klippel A, Murlin AJ, Fantl WJ, Williams LT . 1995 Science 268: 100–102
Imai Y, Clemmins DR . 1999 Endocrinology 40: 4228–4235
Kanda S, Hodgkin MN, Woodfield RJ, Wakelman MJ, Thomas G, Claesson-Welsh L . 1997 J. Biol. Chem. 272: 23347–23353
Kent KC, Mii S, Harrington EO, Chang JD, Malette S, Ware JA . 1995 Cir. Res. 77: 231–238
Kerkhoff E, Rapp UR . 1998 Oncogene 17: 1457–1462
Lane HA, Fernandez A, Lamb NS, Thomas G . 1993 Nature 363: 170–172
Marumo T, Noll T, Schini-Kerth VB, Harley EA, Duhault J, Piper HM, Busse R . 1999 J. Vasc. Res. 36: 510–515
Marthe BM, Downward J . 1997 22: 355–358
Mounho BJ, Thrall BD . 1999 Toxicol. Appl. Pharmacol. 529: 125–133
O'Gorman DM, McKenna SC, Mc Gahon AJ, Knox KA, Colter TG . 2000 Leukemia. 14: 602–611
Pedram A, Razardi M, Levin ER . 1998 J. Biol. Chem. 273: 26722–26728
Qiu MS, Green SH . 1992 Neuron. 9: 705–717
Rikitake Y, Kawashima S, Yamashita T . 2000 Artheriosler. Tromb. Vasc. Biol. 20: 1006–1012
Ryan SJ, Stout JT, Dugel PU . 1994 In: Ryan SJ, (ed). Retina 2 St Louis: Mosby pp 1027–1048
Scheid MP, Poronoi V . 1996 J. Biol. Chem. 271: 18134–18135
Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbin I, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P . 1998 J. Cell. Biol. 141: 1659–1673
Shen WY, Yu MJ, Barry CJ, Constable IJ, Rakocczy PE . 1998 Br. J. Ophthalmol. 82: 1063–1071
Spaks SH . 1973 Br. J. Ophthalmol. 57: 951–965
Stephens LR, Jackson TR, Hawkins PT . 1993 Biochem. Biophys. Acta. 1179: 27–75
Tazake K, Abe M, Sato Y . 2000 Jpn. J. Cancer Res. 90: 647–654
Tudan C, Jackson JK, Charlton L, Pelech SL, Sahl B, Burt HM . 1998 Biochem. J. 331: 531–537
Vinals F, Chambard JC, Pouyssegur J . 1999 J. Biol. Chem. 274: 26776–26782
Wada M, Ogata N, Otsuji T, Uyama M . 1999 Exp. Eye Res. 18: 203–213
Wang D, Yu X, Becker P . 1998 J. Biol. Chem. 273: 33027–33044
Weng QP, Andrali K, Klippel A, Kozlowsky MT, William LT, Avruch J . 1995 Proc. Natl. Acad. Sci. 92: 11696–11700
Wennström S, Downward J . 1999 Moll. Cell Biol. 19: 4279–4288
Wu LW, Mayo LD, Dunbar JD, Kessler KM, Baerwald MR, Jaffe EA, Wang D, Warren RS, Donner DB . 2000 J. Biol. Chem. 275: 5096–5103
Wu LW, Mayo LD, Dunhar JDJ . 2000 Biol. Chem. 257: 5096–5103
Yu Y, Sato JD . 1999 J. Cell. Physiol. 176: 235–246
Acknowledgements
We thank Dr Jean Plouet for his generous gift of VEGF. This work was supported by the Association pour la Recherche sur le Cancer (Contract number 9697, Frédéric Mascarelli) and the Association Claude Bernard (Anna Zubilewicz).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zubilewicz, A., Hecquet, C., Jeanny, JC. et al. Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: A comparative study with VEGF. Oncogene 20, 1403–1413 (2001). https://doi.org/10.1038/sj.onc.1204231
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204231
Keywords
This article is cited by
-
FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytes
Scientific Reports (2019)
-
Retinal and choroidal angiogenesis: a review of new targets
International Journal of Retina and Vitreous (2017)
-
Modulation of unloading-induced bone loss in mice with altered ERK signaling
Mammalian Genome (2016)
-
Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy
European Journal of Medical Research (2012)
-
Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis
Graefe's Archive for Clinical and Experimental Ophthalmology (2009)